Topics
View Supplement
Jessica Lee, BS; Linnet Rodriguez, MD; Meera D. Sivalingam, MD; and Yoshihiro Yonekawa, MD
Natasha Ferreira Santos da Cruz, MD; Ashley Lopez-Canizares, MS; and Audina M. Berrocal, MD
Rachel S. Kim, BS; Kushal U. Agrawal, MS; and Carol L. Shields, MD
November/December 2022 Insert
Sponsored by NIDEK
Editorially independent content supported by advertising from Genentech
Sponsored by Allergan
Supported by Ocular Therapeutix, Inc.
November/December 2022 Supplement
This activity is provided by PRIME Education.
This activity is supported by an unrestricted educational grant from Regeneron.
This activity is supported by an unrestricted educational grant from EyePoint Pharmaceuticals.
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Editorially independent content supported with advertising by Iveric Bio
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Recent Supplements
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
View Insert
One to Watch: Hong-Uyen Hua, MD
Editorially independent supported by Abbvie and Regenxbio
Navigating Copays in Retina Care
Rising Stars in Retina: Fares Antaki, MDCM
Understanding Fast Progression in Geographic Atrophy
One to Watch: Jordan D. Deaner, MD
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE
